Bull-run enters 6th day; Sensex soars 617 pts, Nifty ends above 15,100

Weightage-wise, Infosys (up 3 per cent), Reliance Industries, ICICI Bank, M&M, and TCS contributed around 408-points towards overall gains on the index

1:39 PM

Nifty PSU Bank index slips into red

1:30 PM

RBI plans Rs 3 trillion in sovereign bond purchases to cap yield at 6%

The Reserve Bank of India has so far bought about Rs 2.5 trillion of net debt in the current financial year. The figure will be as high as Rs 3 trillion by end-March as authorities are keen to shrink the spread between the 10-year bond yield and repo rate to around 150 basis points from more than 200 basis points, the person said, asking not to be identified discussing private deliberations. READ MORE

1:22 PM

BHEL slips 9% on posting Rs 231 crore loss in December quarter

Shares of Bharat Heavy Electricals Limited (BHEL) slipped 9 per cent to Rs 39.55 on the BSE in Monday's intra-day trade, in an otherwise strong market, after the company reported a loss of Rs 231 crore in the December quarter (Q3FY21) due to poor operational performance. The state-owned heavy equipment company had posted a profit after tax of Rs 159 crore in Q3FY20. READ MORE

1:12 PM

Q&A | Easy money is not going away: Ashmore Group head of research Jan Dehn

Market participants heaved a sigh of relief after the government presented a pro-growth Budget that did not have any major tax implication for investment in the capital markets.

 

London-based JAN DEHN, head of research at Ashmore Group, which has nearly $100 billion worth of assets under management, tells Puneet Wadhwa in an interview that if the finance minister and her team do not deliver on any of what they have proposed, the market can come off hard. READ FULL INTERVIEW HERE

JAN DEHN Head of research, Ashmore Group

1:12 PM

India VIX jumps 3%, tops 24 level

>> VIX is a measure of volatility in the market

1:11 PM

MARKET UPDATE:: Broader indices outrun benchmarks

1:00 PM

Buzzing Stock :: BHEL tanks 8% post Q3 numbers

>> The company reported a consolidated net loss of Rs 217.86 crore for the October-December quarter.

12:47 PM

A good time to buy real estate and related stocks, say analysts

With the economic recovery picking up pace and attractive home prices, analysts say it is a good time for investors to put in money in stocks of real estate companies. Those who have spare funds and are looking to invest, buying a residential property now can is also be a good option from a long-term perspective. However, the return expectation of investors from these two asset classes should be realistic, especially from the stock market perspective, given the sharp run up in these counters since their March 2020 low. READ MORE

 

12:38 PM

Top Sensex contributors at this hour

12:38 PM

Nifty Bank index climbs off day's high

12:23 PM

Bajaj Electricals zooms 50% in three days post December quarter results

Bajaj Electricals shares zoomed 20 per cent to hit a new high of Rs 1,106 in intra-day trade on the BSE on Monday. The stock has now rallied 50 per cent in three days after the company reported robust consolidated net profit of Rs 98 crore in the December quarter (Q3FY21), on strong performance by consumer products (CP) business. The household appliances maker had recorded a profit of Rs 9 crore in the year-ago quarter. READ MORE
 

12:14 PM

Small-caps may outrun mid-caps in near-term, charts show

In the previous week, the frontline indices surged over 9 per cent, clocking their best-ever weekly gains (in percentage terms) in 10 months. In absolute terms, gains of nearly 1,300 points in Nifty and 4,446 points in S&P BSE Sensex were the best-ever the markets have seen. The broader markets, however, didn't replicate the rally to exact extent with the Nifty MidCap 100 index surging 7.2 per cent on the NSE while the Nifty SmallCap 100 index leaped 6.4 per cent, ACE Equity data show. READ MORE

12:05 PM

Alembic Pharma gets five observations from USFDA for Gujarat facility

Alembic Pharmaceuticals on Monday said the US health regulator has made five observations after inspection at its facility at Karkhadi, Gujarat. The United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' New Injectable Facility (F-3) located at Karkhadi from January 29-February 5, 2021. This was a scheduled inspection and at the end of the inspection, the USFDA issued a form 483 with 5 observations, the company said in a regulatory filing.

(Text Source: PTI)
 

11:59 AM

Project pipeline, ongoing expansion offer revenue visibility for Divi's

Divi’s Laboratories quarter results: After a 49 per cent y-o-y growth in the June quarter and a 21 per cent uptick in the September quarter, Divi’s Laboratories continued its strong growth run in the December quarter.

 

The country’s second largest pharma company by market capitalisation posted a 22 per cent growth in Q3 led by the generics segment which accounts for 60 per cent of its revenues. READ MORE

11:58 AM

MARKET UPDATE:: Sensex holds on to early gains